NEW YORK, Nov 7 (Reuters) - Privately held Prometheus Laboratories Inc said on Wednesday it has agreed to acquire exclusive U.S. rights to GlaxoSmithKline's irritable bowel syndrome drug Lotronex.
Case Name: Prometheus Labs, Inc. v. Roxane Labs, Inc., Case Nos. 11-230 (FSH), 11-1241 (FSH), Unpublished (D.N.J. May 21, 2014) (Hochberg, J.) Drug Product and Patent ...
It looks like Mayo Clinic lost its legal dispute with Prometheus Labs over the patenting of standards for a diagnostic test. This is a deal that went to the Supreme Court about six months ago. It ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback